Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations Biotech Investing
BioStem Technologies Announces the Engagement of Investment Banking Firm Young America Capital for $15 Million Offering. Biotech Investing
Seattle Genetics Receives European Commission Approval for Lymphoma Drug, Expected to Boost Sales Biotech Investing
